rs4669778

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001261428.3(LPIN1):​c.139-21679T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.529 in 151,988 control chromosomes in the GnomAD database, including 22,765 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 22765 hom., cov: 32)

Consequence

LPIN1
NM_001261428.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.508

Publications

6 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.738 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001261428.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001261428.3
c.139-21679T>C
intron
N/ANP_001248357.1Q14693-7
LPIN1
NM_001349207.2
c.82-21679T>C
intron
N/ANP_001336136.1
LPIN1
NM_001349208.2
c.139-21679T>C
intron
N/ANP_001336137.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000396098.5
TSL:1
c.9+2426T>C
intron
N/AENSP00000379405.1Q14693-6
LPIN1
ENST00000449576.6
TSL:2
c.139-21679T>C
intron
N/AENSP00000397908.2Q14693-7
LPIN1
ENST00000396097.5
TSL:5
c.9+2426T>C
intron
N/AENSP00000379404.2Q14693-5

Frequencies

GnomAD3 genomes
AF:
0.529
AC:
80275
AN:
151870
Hom.:
22740
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.745
Gnomad AMI
AF:
0.547
Gnomad AMR
AF:
0.464
Gnomad ASJ
AF:
0.451
Gnomad EAS
AF:
0.236
Gnomad SAS
AF:
0.390
Gnomad FIN
AF:
0.428
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.464
Gnomad OTH
AF:
0.498
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.529
AC:
80354
AN:
151988
Hom.:
22765
Cov.:
32
AF XY:
0.521
AC XY:
38691
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.745
AC:
30861
AN:
41446
American (AMR)
AF:
0.464
AC:
7089
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.451
AC:
1565
AN:
3470
East Asian (EAS)
AF:
0.236
AC:
1218
AN:
5152
South Asian (SAS)
AF:
0.389
AC:
1877
AN:
4820
European-Finnish (FIN)
AF:
0.428
AC:
4530
AN:
10582
Middle Eastern (MID)
AF:
0.432
AC:
126
AN:
292
European-Non Finnish (NFE)
AF:
0.464
AC:
31551
AN:
67936
Other (OTH)
AF:
0.494
AC:
1041
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1797
3594
5391
7188
8985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.481
Hom.:
10770
Bravo
AF:
0.540
Asia WGS
AF:
0.320
AC:
1113
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
6.6
DANN
Benign
0.74
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4669778; hg19: chr2-11883980; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.